Articles | EuroIntervention

EAPCI Column

Jun 2, 2025

EAPCI Focus on the EAPCI Gender and Disparities Committee: An Interview with the Chair Marta Kaluzna-Olesky

free

Editorial

10.4244/EIJ-E-25-00018 • Jun 2, 2025

Using pericoronary fat attenuation to guide management after coronary interventions

Antoniades C, Chan K

free

Editorial

10.4244/EIJ-E-25-00014 • Jun 2, 2025

Polymer-free biolimus-eluting stents: there is no such thing as a free lunch

Piccolo R, Spitzer E

free

Expert consensus

10.4244/EIJ-D-24-00954 • Jun 2, 2025

A new implanter classification system for left atrial appendage closure from the European Left Atrial Appendage Closure Club (ELAACC)

Nielsen-Kudsk J, Aminian A, Backer O, Iriart X, Berti S, Galea R, Freixa X, Räber L, Cruz-González I, Wunderlich N, Garot P

free

Original Research

10.4244/EIJ-D-24-00971 • Jun 2, 2025

Impact of pericoronary adipose tissue attenuation on clinical outcomes after percutaneous coronary intervention

Naniwa S, Kawamori H, Toba T, Hiromasa T, Sugizaki Y, Sasaki S, Fujii H, Hamana T, Osumi Y, Yamamoto T, Iwane S, Sakamoto Y, Matsuhama K, Fukuishi Y, Tsunamoto H, Higuchi K, Okamoto H, Iwasaki M, Takaya T, Yamada S, Hirata K, Otake H

Original Research

10.4244/EIJ-D-24-00586 • Jun 2, 2025

Five-year outcomes of a drug-coated polymer-free biolimus-eluting stent versus an ultrathin-strut biodegradable-polymer sirolimus-eluting stent

Jensen L, Jakobsen L, Eftekhari A, Ellert-Gregersen J, Støttrup N, Engstrøm T, Kahlert J, Freeman P, Veien K, Jensen R, Lassen J, Junker A, Christiansen E

Original Research

10.4244/EIJ-D-24-00763 • Jun 2, 2025

Everolimus-eluting versus biolimus-eluting stents with biodegradable polymers in unselected patients undergoing percutaneous coronary intervention: five-year results of the randomised, non-inferiority SORT OUT VIII trial

Støttrup N, Christiansen E, Raungaard B, Kahlert J, Terkelsen C, Kristensen S, Thim T, Jakobsen L, Jensen R, Eftekhari A, Freeman P, Jensen S, Veien K, Jensen L, Maeng M, for Randomized Trials with Clinical Outcome (SORT OUT) ftSO

Intro editorial

May 16, 2025

Our 20th anniversary EuroPCR edition with a State-of-the-Art on the treatment of patent foramen ovale; an expert review of leaflet modification techniques during TAVI; long-term structural valve deterioration after TAVI; ticagrelor monotherapy; cangrelor in acute and chronic coronary syndromes; rationale and design of the COMPARE STEMI ONE trial; OCT versus IVUS in patients with and without acute coronary syndromes; and more

Capodanno D

free

Editorial

10.4244/EIJ-E-25-00015 • May 16, 2025

Ticagrelor-based antiplatelet therapy after percutaneous coronary intervention in chronic coronary syndrome

Watanabe H, Kimura T

free

Editorial

10.4244/EIJ-E-25-00008 • May 16, 2025

Platelet reactivity when switching from cangrelor to oral P2Y12 receptor inhibitors: insights from a real-world registry

Franchi F, Laudani C

free

Viewpoint

10.4244/EIJ-E-25-00017 • May 16, 2025

Restoring Europe's global position in medical device innovation

Gilard M, Prendergast B, Wijns W, Baumbach A, Maisano F, of the PCR Board o

Viewpoint

10.4244/EIJ-D-24-01198 • May 16, 2025

Unblinded trials of transcatheter interventions with subjective endpoints: what are the implications?

Kaul S

State-of-the-Art

10.4244/EIJ-D-23-00915 • May 16, 2025

Treatment of patent foramen ovale

Pristipino C, Carroll J, Mas J, Wunderlich N, Søndergaard L

free

Expert Review

10.4244/EIJ-D-24-00972 • May 16, 2025

Leaflet modification techniques to mitigate coronary obstruction risk during transcatheter aortic valve implantation

Goel S, Tanner R, Chan K, Khan J, Vinayak M, Lerakis S, Safi L, Khera S, Krishnamoorthy P, Kini A, Sharma S, Dangas G, Tang G

Original Research

10.4244/EIJ-D-24-00662 • May 16, 2025

Long-term structural valve deterioration after TAVI: insights from the EORP ESC Valve Durability TAVI Registry

Giannini C, Capodanno D, Toth G, Windecker S, Schüpke S, Blackman D, Noble S, Eltchaninoff H, Fiorina C, Chieffo A, Bartorelli A, Schmidt A, De Backer O, Gilard M, Curtis E, L’Official G, Donal E, Laroche C, Prendergast B, Petronio A, the European Valve Durability TAVI Registry investigators o